CONTEXT AND OBJECTIVE: Hematopoietic stem cell transplantation (HSCT) has been widely used for treating oncological and hematological diseases. Although HSCT has helped to improve patient survival, 
INTRODUCTION
Hematopoietic stem cell transplantation (HSCT) has been widely used for treating oncological and hematological diseases.
Although its use has increased patient survival, the risk of infection is an important cause of morbidity and mortality among those undergoing this therapeutic approach. 1 In spite of lower infection rates with autologous bone marrow transplantation (BMT), in comparison with allogeneic BMT, infection is the second most frequent cause of death among patients undergoing autologous BMT, and is second only to disease relapse. 2, 3 Patient who have undergone autologous BMT are at higher risk of infection during the neutropenia period, and for up to 30 days after bone marrow grafting. The neutropenia period and breach of the mucocutaneous barrier are the main risks for development of infections. 4, 5 Hospital-acquired infection rates among HSCT patients depend on disease severity, drugs used and invasive procedures performed. 6 Furthermore, the more severe the neutropenia is, the more frequent and aggressive the infections are. 4 
OBJECTIVE
Taking into account the susceptibility of autologous BMT patients to infection during the neutropenia period, we assessed the infectious events occurring during hospitalization and their associated risk factors.
METHODS
One hundred and fifteen patients underwent autologous BMT at the University Hospital, Universidade Federal de Juiz de Fora (UFJF), between 2004 and 2009. Of these, 112 patients developed febrile neutropenia, and were analyzed. This study was approved by the research ethics committee of the University Hospital, UFJF.
All patients received antiviral prophylaxis consisting of acyclovir 240 mg/m 2 /day, divided into four doses, until they received the graft, and also received granulocyte colony-stimulating factor (G-CSF), 5 mg/kg/day, in accordance with our local protocol.
Three blood samples were obtained for blood cultures: one from each line of the central venous catheter and one from peripheral blood. Empirical treatment with cefepime (4 g/day, divided into two doses) was instituted for every neutropenic patient with fever.
Febrile neutropenia was considered to be present whenever a patient with a neutrophil count below 500/mm 3 , or below 1,000/mm 3 but predicted to fall to below 500/mm 3 , 7 developed a single axillary temperature reading ≥ 38 °C, or two readings ≥ 37.5 °C within a 12-hour period. Cultures of samples obtained from different sites were performed whenever a specific infectious site was suspected.
After three days of treatment, the patients were reassessed and, if the fever persisted, a new blood culture was performed.
The empirical therapeutic regimen was adjusted in accordance with the recommendations of the Centers for Disease Control and Prevention (CDC). 
RESULTS
Out of the 115 patients who underwent autologous BMT, 112
developed febrile neutropenia (97.39%). The median age of this latter group was 43 years (range: 8-69 years). Table 1 shows the characteristics of the study population.
The neutropenia period ranged from four to 25 days (median: nine days). Multiple myeloma patients remained neutropenic for seven days, on average, while those with lymphoma remained neutropenic for 12 days, on average (P < 0.001). Although the difference between the groups was significant, the duration of neutropenia was not associated with occurrences of infection (P = 0.323). There was no impact on the number of infused cells on occurrences of infection (P = 0.129).
Six out of 60 patients with positive blood culture had more than one microorganism. Eighty-five instances of infection were identified in 63 patients (57.2% of the study population), of whom 22 (34.9%) had a second source of infection. Table 3 shows the sources of infections identified in the study population.
The catheter was the main infection source identified in the study population, and accounted for the infections of 29 patients (25.9% of the study population). Catheter-related infection was caused by Gram-positive bacteria in 48.3% of the cases (P < 0.001).
An analysis was made between different risk factors and occurrences of infection. Two cases were taken to be missing data, since it was not possible to determine the occurrence of infection. Table 4 shows the results from this analysis. 
Infection-associated factors
Mucositis (P = 0.04) and pulmonary complications (P = 0.002) during hospitalization were the only variables with a statistically significant impact on the occurrence of infection, on univariate analysis. Patients with higher grades (III and IV) of mucositis developed infections more frequently (P = 0.02).
Patients with associated comorbidities, such as diabetes mellitus and systemic arterial hypertension, were more likely to develop infection, although this was not statistically significant (P = 0.05).
Both variables that showed statistical significance in relation to infection on univariate analysis (mucositis and pulmonary complications) were included in the logistic regression models.
The results from this model are shown in Table 5 . Only pulmonary complications remained an independent risk on multivariate analysis (P = 0.015), with an odds ratio of 13. Although the confidence interval of the odds ratio for the variable of pulmonary complications was large, this was due to the low frequency of events. Nonetheless, 14 out of the 15 individuals who had pulmonary complications developed infections, which shows that there was a strong association between these variables. Even though the P value related to mucositis was slightly above 5%, stratified analysis showed that among individuals who did not have pulmonary complications, the infection rate was significantly higher among patients who developed mucositis (P = 0.032). 
DISCUSSION
In this study, 57.2% of the population had an infection identified during hospitalization. According to published data from a single Brazilian center, the infection rate among a pediatric population undergoing allogeneic and autologous BMT was 58.5%. 9 In a multicenter study undertaken in southern and southeastern Brazil, the infection rate was 55%. 2 Although these values are similar to ours, the comparison is hampered because we studied patients undergoing autologous BMT alone.
Studies in other countries on patients undergoing autologous BMT have indicated infection rates ranging from 27.6%
to 48.2%, 10, 11 i.e. lower than the rate that we found. Although not statistically significant, there was a difference in the occurrence of infection in relation to the first years covered by this study. This might be accounted for by the little experience of managing autologous BMT patients that existed in those early days, which may have led to infection rates that were higher than those in the literature.
In disagreement with the literature, 5,12,13 age was not associated with the risk of infection in our study. This finding was possibly due to the small number of children in our sample.
In agreement with the findings of Poutsiaka et al., 14 the length of the neutropenia period was not significantly associated with higher rates of infectious complications in our study.
The same was observed in the study by Ninin et al., 15 in which patients undergoing autologous and allogeneic BMT had similar infection rates.
Although not statistically significant, multiple myeloma patients had the lowest infection rates, a finding that is similar to the data reported by Meyer et al. 16 According to Gil et al., 10 acute myeloid leukemia patients undergoing autologous BMT have the highest risk of infection, since they remain neutropenic for longer periods. In our study, there was no association between the conditioning regimen and infection. The most common infection source was the catheter (34.1%). Our data were very close to those of Nucci and We also made this observation, such that patients with mucositis of grades III and IV had higher infection rates.
Infection-related pulmonary complications have been considered to be important determiners of morbidity and mortality. According to Meyer et al., 16 pneumonia was the second most frequent cause of infection in these patients, occurring in 7.8% of the cases. According to Dettenkofer et al., 6 pneumonia is the most frequent infection in patients undergoing autologous BMT.
Three patients had oxacillin-resistant Staphylococcus aureus. This microorganism increases the infection-related mortality rate of grafted patients, and has been isolated with higher frequency, in different places, over the past few years. 17 No vancomycin-resistant microorganism was isolated in our study.
In accordance with the Brazilian and foreign literature,
Gram-positive bacteria were the most frequent isolates in our study. Nonetheless, a significant increase in the number of infections due to Gram-negative bacteria has been reported over the past few years. 1, 7, 12, [18] [19] [20] [21] This may be accounted for by greater use of prophylactic antimicrobials, chiefly quinolones. 22 According to Laws et al., 19 Gram-negative bacterial infections are more severe and cause higher death rates, compared with Gram-positive bacterial infections. This may be explained by their greater virulence and resistance, and the latter is also due to their double cell membrane, which blocks the entry of some drugs. 23 The most frequent isolate in our study was coagulase-negative Staphylococcus, in agreement with findings from different BMT centers. 6, 15, 16, 19, 24, 25 Until recently, these bacteria were considered contaminants, devoid of serious clinical importance. 26 However, over the past few years, they have been acknowledged as important infectious agents. Catheters are the main means of entry for these microorganisms. 26 Fungi were the second most frequently identified microorganisms in the infections we found. The main isolate was Candida albicans, and its presence was associated with mucositis. In autologous BMT, the likelihood of systemic candidiasis is very low, and occurs chiefly after the neutropenia period has resolved, or in the absence of mucositis. 27 Similarly to findings from other centers, 2, 8, 11, 14 infection was the main cause of death in our patients during hospitalization. It seemed to contribute towards longer hospital stay, although this association did not present statistical significance (P = 0.081).
CONCLUSIONS
The infection rate found among patients undergoing BMT was high (57.2%), and the main source was the catheter (34.1%).
We believe that continuing training programs and basic preventive measures, targeted to reduce infectious complications during the hospitalization of patients undergoing BMT, are paramount. Further studies are necessary before more effective measures to protect this infection-prone population can be implemented.
